389P Efficacy and safety of sintilimab in combination with anlotinib plus metronomic chemotherapy in advanced triple negative breast cancer (SPACE): Preliminary results of a single-arm, multicenter phase II trialHan Li, Zhi Shi, G. ren et al.|Annals of Oncology|2024Cited by 0